Veeva R&D and Quality Summit Europe Brings Pharma Industry Together to Streamline Drug Development

(Adnkronos) – Life sciences leaders convene to break barriers in advancing digital trials and product development                             

BARCELONA, Spain, June 22, 2022 /PRNewswire/ — One of the largest European events of its kind, Veeva R&D and Quality Summit Europe recently gathered more than 500 life sciences leaders in Zurich to discuss new approaches for advancing digital trials and driving transformation in clinical, quality, regulatory, and safety. 

“The exchange of ideas with my peers at Veeva R&D and Quality Summit was invaluable,” said Martijn van de Leur, global pharmacovigilance leader at Biomapas. “It is truly a community of like-minded professionals who are passionate about improving health outcomes for patients through innovation.” 

Steve Guise, CIO, Roche Pharmaceuticals division, kicked off the event with his keynote highlighting the company’s ambitious goal of generating three to five times the benefit to patients at half the cost to society by leveraging a modern technology foundation. 

Attendees learned about industry-leading strategies to streamline processes across the product lifecycle, such as: 

“The deep knowledge and experience leaders brought to the Veeva R&D and Quality Summit Europe helped people understand what it takes to create more efficient, faster ways to bring medicines to patients,” said Chris Moore, president of Veeva Europe. “These innovative strategies can ultimately drive the whole industry forward.” 

Life sciences industry professionals who couldn’t attend the event can watch Veeva R&D and Quality Summit Europe
keynote and sessions. 

Additional InformationConnect with Veeva on LinkedIn: Follow @veeva_eu on Twitter:  

Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit 


Jeremy WhittakerVeeva Systems+49

Logo –  


Lascia un commento

Il tuo indirizzo email non sarà pubblicato.

Questo sito usa Akismet per ridurre lo spam. Scopri come i tuoi dati vengono elaborati.

Articolo precedente

Riassunto: Echosens e Novo Nordisk annunciano una collaborazione per la maggior consapevolezza e il progresso nella diagnosi precoce della NASH

Articolo successivo

SIRTLab Corporation Appoints Michael G. Kauffman, MD, PhD, as Co-Chairman of the Board of Directors and Chief Medical Officer

Articoli correlati